Navigation Links
Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants

the six-week randomized treatment phase during which they continued their ADT plus double-blind adjunctive placebo or adjunctive aripiprazole (2-20 mg/day).

The primary efficacy endpoint was the mean change from baseline - the end of the prospective treatment phase - to the end of the randomized treatment phase in a standard measure called the MADRS Total Score, which can range from 0 (no symptoms) to 60 points (most severe symptoms). A reduction in MADRS Total Score represents improvement in depressive symptoms. Some of the secondary endpoints included Sheehan Disability Scale (SDS), MADRS-measured remission and response rates and Clinical Global Impression-Severity of Illness (CGI-S) score.

For the primary endpoint, the study showed that adults taking adjunctive aripiprazole had a greater reduction in MADRS Total Score from baseline compared to placebo (-8.8 vs. -5.8 points, p-value less than 0.001).

The discontinuation rate due to an adverse event for adults taking add-on aripiprazole was 3.3 percent and 2.3 percent for placebo. The most common adverse events in the add-on aripiprazole and add-on placebo groups, respectively, (greater than or equal to 5 percent and at least twice the incidence of placebo) were akathisia (23.1 percent vs. 4.5 percent), insomnia (7.7 percent vs. 2.3 percent), restlessness (14.3 percent vs. 3.4 percent), upper respiratory tract infection (8.2 percent vs. 4 percent), and blurred vision (6.6 percent vs. 1.7 percent).

About Major Depressive Disorder

Major depressive disorder (MDD) is characterized by one or more major depressive episodes, (i.e., at least two weeks of depressed mood or loss of interest accompanied by at least four additional symptoms of depression.) (2) It affects 6.7 percent of American adults (approximately 15 million individuals) in a given year(3) and is the most common mental health disorder after anxiety.(4)

About Aripiprazole

Aripiprazole is indicated for the treat
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
... VANCOUVER, British Columbia, June 21, 2011 Enox Biopharma, Inc. ... East Investment in Innovation Conference on Wednesday, June 22 at ... Hyatt Regency Hotel in Boston. The IN3 ... and networking meeting. The meeting is designed to provide exposure ...
... Robbins & Myers, Inc. (NYSE: RBN ... approved its regular quarterly cash dividend payment of $0.045 ... 2011 to shareholders of record as of July 8, ... leading supplier of engineered equipment and systems for critical ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2
(Date:5/20/2013)... News) -- A new Canadian study has uncovered an ... less likely than men to get trauma center care ... to health care services in general have been recognized ... disparities extend to the treatment of severe injuries in ... at Sunnybrook Health Sciences Centre and the University of ...
(Date:5/20/2013)... 2013 The International Distance Skateboard Association has ... for the best long distance skaters to attend and compete. ... a venue of raising money for our local Boys & ... IDSA is the authority on long distance races throughout the ... event is safe and organized for all who want to ...
(Date:5/20/2013)... 2013 CosmosID, a leading data mining solutions company for ... collaboration results on analysis of labeling claims for the ... , The Food and Drug Administration (FDA) and CosmosID ... probiotics, four of which have been reported at the ... tests was to compare the identity of species and ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... Online education provides the convenience, flexibility ... not offer. According to the American Heart Association, ... classroom learning to eLearning due to changing economic ... maximize training budgets, but it is also proven ... 25–60%. A higher retention of content is probable, ...
Breaking Medicine News(10 mins):Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2
... TORONTO, February 16, 2011 − One of the tough challenges ... how to parent the surviving children, and the task begins ... From the moment their child dies, parents are faced with ... loss of a child and the ongoing, daily demands from ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, ... Physicians has released new guidelines recommending that doctors not ... sugar levels in patients in medical or surgical intensive ... with diabetes and without the condition. The college recommends ...
... screening and treatment of genitourinary cancers were released today in ... February 17-19, 2011, at the Orlando World Center Marriott in ... in a media presscast (press briefing via live webcast): ... cancer death for men with low initial PSAs: A large ...
... with Alzheimer,s disease or other dementias, and their families, ... plan for the patient,s progressive loss of ability to ... physician at the San Francisco VA Medical Center and ... patient is diagnosed with Alzheimer,s disease or dementia, the ...
... Men with prostate cancer may be twice as likely to have ... 20 than those without prostate cancer, a new French study suggests. ... 40s do not appear to face a similar boost in prostate ... do not face a higher risk of developing the cancer at ...
... , TUESDAY, Feb. 15 (HealthDay News) -- A review of ... Americans pop at the first sign of a cold may, in ... conducted by a team in India and published in the ... people have to stay away from work or school. "This ...
Cached Medicine News:Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 3Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Zinc May Help Ease Common Cold: Analysis 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: